Craig A. Rosen
Founder at Teva Biopharmaceuticals USA, Inc.
Profile
Craig A.
Rosen is the founder and currently holds the position of Executive Chairman & Chief Scientific Officer at Teva Biopharmaceuticals USA, Inc., which was founded in 2005.
He also held the position of Chief Scientific Officer at Human Genome Sciences, Inc. from 1992 to 2009.
Additionally, Dr. Rosen has served as Chairman-Scientific Advisory Council at The American Foundation For AIDS Research, Inc. from 1990 to 1995.
He has also held the position of Chief Scientific Officer & Senior Vice President at Teva Pharmaceuticals USA, Inc. Dr. Rosen's education includes undergraduate and doctorate degrees from the University of Rhode Island.
Craig A. Rosen active positions
| Companies | Position | Start |
|---|---|---|
Teva Biopharmaceuticals USA, Inc.
 Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Founder | 07/08/2009 |
Former positions of Craig A. Rosen
| Companies | Position | End |
|---|---|---|
The American Foundation For AIDS Research, Inc.
 The American Foundation For AIDS Research, Inc. Miscellaneous Commercial ServicesCommercial Services The American Foundation For AIDS Research, Inc. provides research services. It plays a role in AIDS research, identifying critical gaps in their knowledge of HIV and AIDS. The company was founded in 1985 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/01/1995 |
The Wistar Institute
 The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Corporate Officer/Principal | - |
Institute of Human Virology
 Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Corporate Officer/Principal | - |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Chief Tech/Sci/R&D Officer | - |
| PHASEBIO PHARMACEUTICALS, INC. | Chairman | - |
Training of Craig A. Rosen
| University of Rhode Island | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
The American Foundation For AIDS Research, Inc.
The American Foundation For AIDS Research, Inc. Miscellaneous Commercial ServicesCommercial Services The American Foundation For AIDS Research, Inc. provides research services. It plays a role in AIDS research, identifying critical gaps in their knowledge of HIV and AIDS. The company was founded in 1985 and is headquartered in New York, NY. | Commercial Services |
Teva Biopharmaceuticals USA, Inc.
Teva Biopharmaceuticals USA, Inc. BiotechnologyHealth Technology Teva Biopharmaceuticals USA, Inc. develops and commercializes biological products. It uses albumin-fusion technology to develop and commercialize certain albumin-fusion proteins for therapeutic use. The company was founded by Craig A. Rosen, Steven C. Mayer, Indra Sanyal and Mark A. Rampy in 2005 and is headquartered in Rockville, MD. | Health Technology |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Teva Pharmaceuticals USA, Inc. engages in the manufacturing and marketing of generic pharmaceuticals. The firm also provides medical affairs, quality plus safety and trade partner services. The company was founded in 1985 and is headquartered in Parsippany, NJ. | Health Technology |
Institute of Human Virology
Institute of Human Virology Other Consumer ServicesConsumer Services The Institute of Human Virology (IHV) is a research institute located in Baltimore, MD, affiliated with the University of Maryland School of Medicine. The IHV is the first research institute in the US to link basic science, population studies, and clinical trials in an effort to develop new vaccines and treatments for chronic viral diseases such as HIV/AIDS, hepatitis C, hepatitis B, and human papillomavirus infection. The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV also provides compassionate cutting-edge care and specializes in the treatment of HIV/AIDS and other chronic viral diseases. | Consumer Services |
The Wistar Institute
The Wistar Institute BiotechnologyHealth Technology The Wistar Institute provides biomedical research services. It researches on diseases such as cancer, cardiovascular, autoimmune disorders and infectious diseases and develops vaccine. The company was founded in 1892 and is headquartered in Philadelphia, PA | Health Technology |
- Stock Market
- Insiders
- Craig A. Rosen
